Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.700
+0.040 (1.50%)
At close: Aug 13, 2025, 4:00 PM
2.660
-0.040 (-1.48%)
Pre-market: Aug 14, 2025, 9:08 AM EDT

Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $249.07 million as of August 14, 2025. Its market cap has increased by 55.38% in one year.

Market Cap
249.07M
Enterprise Value
247.83M
1-Year Change
55.38%
Ranking
Category
Stock Price
$2.70

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $249.07M, an increase of 36.03%. That is a compound annual growth rate of 1.47%.

History

DateMarket Cap% Change
Aug 13, 2025232.20M20.19%
Dec 31, 2024193.20M36.54%
Dec 29, 2023141.50M-8.65%
Dec 30, 2022154.90M-66.50%
Dec 31, 2021462.40M23.27%
Dec 31, 2020375.10M6.26%
Dec 31, 2019353.00M474.92%
Dec 31, 201861.40M237.36%
Dec 29, 201718.20M28.17%
Dec 30, 201614.20M-10.69%
Dec 31, 201515.90M-47.52%
Dec 31, 201430.30M-47.49%
Dec 31, 201357.70M215.30%
Dec 31, 201218.30M-55.90%
Dec 30, 201141.50M-76.45%
Dec 31, 2010176.20M-2.22%
Dec 31, 2009180.20M19.97%
Dec 31, 2008150.20M-63.64%
Dec 31, 2007413.10M27.11%
Dec 29, 2006325.00M49.56%
Dec 30, 2005217.30M991.96%
Dec 31, 200419.90M-89.13%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 592.95B
Johnson & Johnson 420.06B
AbbVie 355.91B
UnitedHealth Group 246.17B
AstraZeneca 240.81B
Novartis AG 234.72B
Novo Nordisk 227.37B
Abbott Laboratories 225.22B
Market Cap Rankings